These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3008680)

  • 21. Sex as a risk factor for HTLV-I spread among intravenous drug abusers.
    Rezza G; Titti F; Rossi GB; Verani P; Menniti-Ippolito F; Oliva C
    Lancet; 1988 Mar; 1(8587):713. PubMed ID: 2895250
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous drug abuse and the accident and emergency department: AIDS (HTLV-III) antibodies and hepatitis B markers.
    Dunlop MG; Steedman DJ; Peutherer JF
    Arch Emerg Med; 1986 Dec; 3(4):257-9. PubMed ID: 3026414
    [No Abstract]   [Full Text] [Related]  

  • 23. High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol.
    Fuchs D; Blecha HG; Deinhardt F; Dierich MP; Goebel FD; Hengster P; Hinterhuber H; Schoenitzer D; Traill K; Wachter H
    Lancet; 1985 Jun; 1(8444):1506. PubMed ID: 2861431
    [No Abstract]   [Full Text] [Related]  

  • 24. [Laboratory results in the evaluation of anti HTLV-III in subjects at risk].
    Maschio C; Colangeli S; Rughetti A; Fonzi D; Barnabei R; Ciccarella A
    Riv Emoter Immunoematol; 1985; 32(3):302-6. PubMed ID: 3008301
    [No Abstract]   [Full Text] [Related]  

  • 25. More on HTLV-III antibody testing in New York City.
    N Engl J Med; 1986 May; 314(18):1190-1. PubMed ID: 3007988
    [No Abstract]   [Full Text] [Related]  

  • 26. [Occurrence of antibody to human T-cell leukemia/lymphovirus type III (LAV/HTLV III) in venereology clientele in Copenhagen].
    Petersen CS; Wantzin GL; Gerstoft J; Lindhardt BO; Worm AM; Weismann K; Kristensen JK; Kroon S; Rasmussen LP; Avnstorp C
    Ugeskr Laeger; 1986 Mar; 148(14):821-2. PubMed ID: 3010523
    [No Abstract]   [Full Text] [Related]  

  • 27. [Penetration of LAV/HTLV-III and infectious complications in parenteral drug addicts].
    Pachón J; Ollero M; Díaz-Torres MA; Creagh R
    Med Clin (Barc); 1986 Jan; 86(3):131. PubMed ID: 3007884
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 29. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody prevalence in U.S. military recruit applicants.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jul; 35(26):421-4. PubMed ID: 3014305
    [No Abstract]   [Full Text] [Related]  

  • 30. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
    Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA
    Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 32. [Seroepidemiology of the HTLV-III virus in a high-risk Panamanian population. Preliminary report].
    Arosemena JR; Cuevas M; Ulloa E; Guerrero DM; Gómez B; Cantón-Dutary A; Reyes R; Quiroz E; de Britton RM; Brenes MM
    Rev Med Panama; 1986 May; 11(2):124-33. PubMed ID: 3018847
    [No Abstract]   [Full Text] [Related]  

  • 33. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 34. [Syphilis profile among LAV/HTLV III antibody-positive and negative homosexual men].
    Weismann K; Sindrup JH; Wantzin GL
    Ugeskr Laeger; 1986 Mar; 148(14):823-5. PubMed ID: 3010524
    [No Abstract]   [Full Text] [Related]  

  • 35. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
    Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [LAV/HTLV III antibody in patients with acute hepatitis B 1975-1984].
    Arendrup M; Lindhardt BO; Krogsgaard K; Gaub J; Nielsen JO
    Ugeskr Laeger; 1986 Mar; 148(14):825-8. PubMed ID: 3010525
    [No Abstract]   [Full Text] [Related]  

  • 37. HTLV-III antibody in Edinburgh drug addicts.
    Peutherer JF; Edmond E; Simmonds P; Dickson JD; Bath GE
    Lancet; 1985 Nov; 2(8464):1129-30. PubMed ID: 2865601
    [No Abstract]   [Full Text] [Related]  

  • 38. HTLV-III antibody among Italian drug addicts.
    Ferroni P; Geroldi D; Galli C; Zanetti AR; Cargnel A
    Lancet; 1985 Jul; 2(8445):52-3. PubMed ID: 2861509
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidemiological survey of HIV infection in the Veneto region of Italy.
    Chieco Bianchi L; Faulkner Valle G; De Rossi A; Dalla Gassa O
    Biomed Pharmacother; 1987; 41(3):139-43. PubMed ID: 3038208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.